B-cell depletion in patients with multiple myeloma with the anti-CD20 monoclonal antibody rituximab after high dose therapy

被引：0
|
作者：
Witzens, M [1 ]
Gemmel, C [1 ]
Moos, M [1 ]
Goldschmidt, H [1 ]
Ho, AD [1 ]
机构：
[1] Univ Heidelberg, Dept Internal Med 4, D-69115 Heidelberg, Germany
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
465
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [11] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 878 - 878
  • [12] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21): : 2008 - 2016
  • [13] CD20-negative relapse of cutaneous B-cell lymphoma after anti-CD20 monoclonal antibody therapy
    Massengale, WT
    McBurney, E
    Gurtler, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (03) : 441 - 443
  • [14] Quality of life in patients with B-cell lymphoma during maintenance therapy with the Anti-CD20 antibody rituximab
    Witzens-Harig, Mathias
    Heiss, Christiane
    Benner, Axel
    Hensel, Manfred
    Neben, Kai
    Dreger, Peter
    Kraemer, Alwin
    Ho, Anthony D.
    BLOOD, 2007, 110 (11) : 189B - 189B
  • [15] Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B-cell lymphoma
    Roguedas, AM
    Watier, H
    Paintaud, G
    de Muret, A
    Vaillant, L
    Machet, L
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (03) : 541 - 544
  • [16] Maintenance therapy using the anti-CD20 antibody Rituximab in patients with B-cell non-Hodgkin lymphoma
    Neumann, F
    Martin, S
    Kronenwett, R
    Fischer, C
    Kondakci, M
    Kobbe, G
    Gattermann, N
    Haas, R
    BLOOD, 2003, 102 (11) : 298B - 298B
  • [17] Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with Rituximab, a chimeric Anti-CD20 monoclonal antibody
    Soda, R
    Costanzo, A
    Cantonetti, M
    Orlandi, A
    Bianchi, L
    Chimenti, S
    ACTA DERMATO-VENEREOLOGICA, 2001, 81 (03) : 207 - 208
  • [18] Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
    Morrison, LH
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) : 817 - 819
  • [19] Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)
    Bruzzese, V.
    Pepe, J.
    REUMATISMO, 2009, 61 (04) : 306 - 308
  • [20] Treatment with the anti-CD20 antibody Rituximab as consolidation therapy for patients with multiple myeloma after peripheral blood (PB) stem cell transplantation (SCT).
    Cremer, FW
    Gemmel, C
    Witzens, M
    Moldenhauer, G
    Ho, AD
    Moos, M
    Goldschmidt, H
    BLOOD, 2000, 96 (11) : 298B - 298B
12345